Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Stevanato Group S.p.A. (STVN) Q1 2026 Earnings Call Transcript
Stevanato Group (STVN) Q1 Earnings and Revenues Beat Estimates
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026
Stevanato Group to Participate in Three Upcoming Investor Conferences
Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth
Conestoga Capital SMid Cap Composite Q1 2026 Portfolio Holdings
Reviewing Stevanato Group (NYSE:STVN) and Heatwurx (NASDAQ:PCSA)
Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026
ArrowMark Colorado Holdings LLC Grows Position in Stevanato Group S.p.A. $STVN
Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Recommendation of “Moderate Buy” by Analysts
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
Stevanato: Strong Q4 Results Reinforce Long-Term Growth Story
Stevanato Group Q4 Earnings Call Highlights
Stevanato Group (NYSE:STVN) Shares Down 8.5% on Analyst Downgrade
Stevanato Group S.p.A. (STVN) Q4 2025 Earnings Call Transcript
Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates
Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins
Artisan Partners Limited Partnership Has $67.29 Million Stock Holdings in Stevanato Group S.p.A. $STVN
Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026
Financial Review: Kiora Pharmaceuticals (NASDAQ:KPRX) & Stevanato Group (NYSE:STVN)
Stevanato Group (NYSE:STVN) Reaches New 52-Week Low – Time to Sell?
Alger Small Cap Focus Fund Q4 2025 Portfolio Update
STVN or MDGL: Which Is the Better Value Stock Right Now?
Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of “Moderate Buy” by Brokerages
Datwyler, LTS Device Technologies, and Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs
Stevanato: Structural Growth Intact, Buy Confirmed
SDZNY vs. STVN: Which Stock Is the Better Value Option?
SDZNY vs. STVN: Which Stock Should Value Investors Buy Now?
Stevanato Group S.p.A. (STVN) Q3 2025 Earnings Call Transcript
Stevanato Group (STVN) Q3 Earnings and Revenues Surpass Estimates
Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025
SDZNY vs. STVN: Which Stock Is the Better Value Option?
Stevanato Group to Participate in Upcoming Investor Conferences
Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025
Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings
GRFS vs. STVN: Which Stock Should Value Investors Buy Now?
Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2025 Transcript
Stevanato (STVN) Upgraded to Buy: Here's What You Should Know
Stevanato Group S.p.A. (STVN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
USNA or STVN: Which Is the Better Value Stock Right Now?
USNA vs. STVN: Which Stock Is the Better Value Option?
Stevanato Group (STVN) Q2 Earnings and Revenues Beat Estimates
Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025
Stevanato Group (STVN) Earnings Expected to Grow: Should You Buy?
MKKGY or STVN: Which Is the Better Value Stock Right Now?
Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock?
Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.
Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025